The Sputnik V is a COVID- 19 vaccine developed by the Gamalia institute of epidemiology
and microbiology and released on August 11, 2020. We provided independent evidence on …

Background New therapeutic options are urgently needed to tackle the novel coronavirus
disease 2019 (COVID-19). Repurposing existing pharmaceuticals provides an immediate …

Background. Mycobacterium tuberculosis (M. TB) causes a wide spectrum of clinical diseases.
The prevalence of TB is different in various parts of Iran and throughout the world. The …

The occurrence of oral candidiasis (OC) is expected in patients with COVID-19, especially
those with moderate to severe forms of infection who are hospitalized and may be on long-…

Background. Herpes zoster infection is a painful worldwide disease. Inappropriate and
delayed treatment causes prolongation of the disease with debilitating symptoms and …

Empyema necessitans (EN) is a kind of empyema that diffuses to extrapleural space and can
involve chest pain. Tuberculosis (TB) is the most common cause of EN. This disease can …

Background We performed a multicenter, randomized open-label trial in patients with
moderate to severe Covid-19 treated with a range of possible treatment regimens. Methods: …

Background: Infection with Trichostrongylus spp. is common among human and herbivorous
in most parts of Iran, especially in southern and northern areas. The aim of present study …

Brucellosis is an infectious disease caused by gram-negative bacteria of the genus Brucella.
Involvement of the gastrointestinal, hepatobilliary, and skeletal systems has been reported …

Background Ivermectin which was widely considered as a potential treatment for COVID-19,
showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials …